Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
32.15
+0.04 (0.12%)
At close: Sep 2, 2026, 4:00 PM EDT
31.51
-0.64 (-1.99%)
After-hours: Sep 2, 2026, 7:54 PM EDT
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $32.7 million as of September 2, 2026. Its market cap has decreased by -61.95% in one year.
Market Cap
32.70M
Enterprise Value
-83.28M
1-Year Change
-61.95%
Ranking
Category
Stock Price
$32.15
ChartMarket Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.57M to $32.70M, a decrease of -96.18%. That is a compound annual growth rate of -35.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 32.70M | -82.47% |
| Dec 31, 2025 | 186.53M | 126.70% |
| Dec 31, 2024 | 82.28M | 82.80% |
| Dec 29, 2023 | 45.01M | 95.46% |
| Dec 30, 2022 | 23.03M | -93.89% |
| Dec 31, 2021 | 377.06M | -53.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lite Strategy | 35.39M |
| Kyntra Bio | 34.54M |
| TransCode Therapeutics | 34.03M |
| NextCure | 33.64M |
| Context Therapeutics | 33.32M |
| BriaCell Therapeutics | 31.61M |
| Actinium Pharmaceuticals | 31.44M |
| Actuate Therapeutics | 31.22M |